Home/Filings/4/0000950170-24-087381
4//SEC Filing

Moran Kevin Patrick 4

Accession 0000950170-24-087381

CIK 0001347178other

Filed

Jul 28, 8:00 PM ET

Accepted

Jul 29, 5:24 PM ET

Size

5.5 KB

Accession

0000950170-24-087381

Insider Transaction Report

Form 4
Period: 2024-07-29
Moran Kevin Patrick
SVP, CFO & Treasurer
Transactions
  • Sale

    Common Stock

    2024-07-29$5.92/sh2,251$13,327228,763 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    635
Footnotes (1)
  • [F1]Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to the default "same day sale" provisions of the RSU agreements.

Documents

1 file

Issuer

Vanda Pharmaceuticals Inc.

CIK 0001347178

Entity typeother

Related Parties

1
  • filerCIK 0001806596

Filing Metadata

Form type
4
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 5:24 PM ET
Size
5.5 KB